INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX

05.03.25 01:44 Uhr

Werte in diesem Artikel
Aktien

127,00 EUR 1,00 EUR 0,79%

NEW YORK, March 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Teleflex Incorporated ("Teleflex" or the "Company") (NYSE: TFX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Teleflex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On February 27, 2025, in a series of press releases, Teleflex announced its intent "to create a new, independently publicly traded company . . . consisting of Teleflex's Urology, Acute Care, and OEM businesses"; its "ent[ry] into a definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG for an estimated cash payment on closing of approximately €760 million"; and the resignation of Teleflex's Chief Financial Officer. 

Following these announcements, Teleflex's stock price fell $38.52 per share, or 21.69%, to close $139.11 per share on February 27, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-teleflex-incorporated---tfx-302392161.html

SOURCE Pomerantz LLP

Ausgewählte Hebelprodukte auf Teleflex

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Teleflex

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Teleflex Inc.Shs

Wer­bung

Analysen zu Teleflex Inc.Shs

DatumRatingAnalyst
02.08.2019Teleflex BuyNeedham & Company, LLC
24.04.2019Teleflex BuyNeedham & Company, LLC
22.02.2019Teleflex Strong BuyNeedham & Company, LLC
16.10.2018Teleflex Equal WeightBarclays Capital
10.09.2018Teleflex Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
02.08.2019Teleflex BuyNeedham & Company, LLC
24.04.2019Teleflex BuyNeedham & Company, LLC
22.02.2019Teleflex Strong BuyNeedham & Company, LLC
10.09.2018Teleflex Strong BuyNeedham & Company, LLC
03.08.2018Teleflex BuyNeedham & Company, LLC
DatumRatingAnalyst
16.10.2018Teleflex Equal WeightBarclays Capital
16.11.2017Teleflex HoldDeutsche Bank AG
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Teleflex Inc.Shs nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"